Cytosorbents CEO Phillip Chan's 2023 pay rises 20% to $1.3M
Cytosorbents reports 2023 executive compensation
By ExecPay News
Published: April 19, 2024
Cytosorbents reported fiscal year 2023 executive compensation information on April 19, 2024.
In 2023, four executives at Cytosorbents received on average a compensation package of $1.1M, a 9% increase compared to previous year.
Average pay of disclosed executives at Cytosorbents
Phillip P. Chan, Chief Executive Officer, received $1.3M in total, which increased by 20% compared to 2022. 36% of Chan's compensation, or $483K, was in salary. Chan also received $157K in bonus, $375K in option awards, $307K in stock awards, as well as $12K in other compensation.
Vincent J. Capponi, Chief Operating Officer, received a compensation package of $1.1M, which increased by 13% compared to previous year. 38% of the compensation package, or $424K, was in salary.
Efthymios N. Deliargyris, Chief Medical Officer, earned $1.1M in 2023, a 5% increase compared to previous year.
Kathleen P. Bloch, Chief Financial Officer, received $816K in 2023, which decreases by 4% compared to 2022.
Related executives
You may also like
Source: SEC filing on April 19, 2024.